Profitability Ratios
| Ratio |
Value |
| GP Margin |
100.0% |
| EBIT Margin |
-212531.7% |
| EBITDA Margin |
-212258.5% |
| Operating Margin |
-230461.0% |
| Pretax Margin |
-216522.0% |
| Cont. Ops Margin |
-214861.0% |
| Net Margin |
-214861.0% |
| Bottom Line Margin |
-214861.0% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
18.55 |
| Quick Ratio |
18.55 |
| Solvency Ratio |
-1.599 |
| Cash Ratio |
2.92 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.14 |
| Forward PEG |
0.14 |
| Price/Book |
1.41 |
| Price/Sales |
7757.46 |
| Price/FCF |
-4.71 |
| Price/Op Cash Flow |
-4.71 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.1275 |
| Debt/Equity |
0.1587 |
| Debt/Capital |
0.1370 |
| Long-Term Debt/Capital |
0.1323 |
| Financial Leverage |
1.24 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
0.00 |
| Operating Cash Flow Ratio |
-4.503 |
| Operating Cash Flow/Sales |
-164719.5% |
| Free Cash Flow/Operating Cash Flow |
100.0% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
-52.78 |
| Interest Coverage |
-57.7561 |
| Short-Term Operating Cash Flow Coverage |
0.00 |
| Operating Cash Flow Coverage |
-1.89 |
| Capital Expenditure Coverage |
-6139.55 |
| Dividend + Capital Expenditure Coverage |
-6139.55 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
0.00 |
| EPS |
-1.000 |
| Debt/Share |
0.4236 |
| Cash/Share |
3.10 |
| Book Value/Share |
2.55 |
| Tangible BV/Share |
2.55 |
| Equity/Share |
2.55 |
| Operating Cash Flow/Share |
-0.767 |
| Capital Expenditure/Share |
0.000 |
| FCF/Share |
-0.767 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.992 |
| Earnings Before Tax/EBIT |
0.940 |
| Price/Fair Value |
1.41 |
| Debt/Market Cap |
0.1078 |
| Effective Tax Rate |
0.8% |
| Enterprise Value Multiple |
-3.56 |
ALT - Altimmune, Inc.